Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists

Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists

US Patent 12383521 · Granted Aug 12, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapy for the treatment of migraines2025
RXR agonist salt form, polymorphs thereof, and uses thereof2025
VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergi2024
VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergi2024
Methods of using RARγ agonists for cancer treatment2024
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders2024
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders2024
Vista antagonist and methods of use2024
Vista antagonist and methods of use2024
Use of an RXR agonist in treating drug resistant HER2+ cancers2024
RXR agonist salt form, polymorphs thereof, and uses thereof2024
Use of an RXR agonist and taxanes in treating Her2+ cancers2024